Calcium channel blocker nimodipine (Nimotop) in the treatment of soft cognitive disturbances
- Authors: Drapkina OM1, Ashikhmin Y.I1, Drapkina OM1, Ashichmin JI1
-
Affiliations:
- Issue: No 7 (2009)
- Pages: 44-46
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/276813
- ID: 276813
Cite item
Full Text
Abstract
The article is dedicated to the problem of the calcium channel blockers use for treatment of hypertensive patients with cognitive dysfunction. In neurological practice, the well-studied representative of this group is Nimodipine (Nimotop), which was associated with the main hope in the treatment of such patients. Moreover, there is the possibility of nimodipine use in cardiology practice, in particular in patients with coronary heart disease.
References
- Brandt L, et al. Does Nimodipine eliminate arterial hypertension as a prognostic risk factor in SAH. Brit J Neurosurg 1991;5(5).
- de Jonge MC, Traber J. Nimodipine: cognition, aging, and degeneration. Clin Neuropharmacol 1993;16(Suppl. 1):S25-30.
- Fogelholm R, et al. Blood pressure, nimodipine, and outcome of ischemic stroke. Acta Neurologica Scandinavica 2004;109(3):200-04.
- Havanka-Kanniainen H, et al. Efficacy of nimodipine in the prophylaxis of migraine. Cephalalgia 1985;5(1):39-43.
- Juvela S, et al. Effect of Nimodipine on Platelet Function in Patients With Subarachnoid Hemorrhage. Stroke 1990;21:1283-88.
- Keyrouz S, Diringer M. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care 2007;11(4):220.
- Lopez-Arrieta JM, Birks J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Datab Syst Rev 2002;(3):CD000147
- Mancia, G., De Backer, G., Dominiczak, A., et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87.
- Pantoni L, et al. Efficacy and Safety of Nimodipine in Subcortical Vascular Dementia. Stroke 2005;36:619-24.
- Scriabine A, van den Kerckhoff W. Pharmacology of nimodipine. Ann New York Academy Sci 1988;522(1):698-706.
- Wang W, et al. A nimodipine interventional study of patients with mild cognitive impairment. Zhonghua Nei Ke Za Zhi 2006;45(4):274-76.
- Zipes, et al. Braunwald's Heart Disease 8e, NY, 2007:1367-79.
Supplementary files
